[1]
Gonçalves, T. et al. 2024. Successful off-label use of omalizumab in a child with chronic spontaneous urticaria. BIRTH AND GROWTH MEDICAL JOURNAL. 33, 1 (Apr. 2024), 51–55. DOI:https://doi.org/10.25753/BirthGrowthMJ.v33.i1.28163.